How do biotech B2B sales orgs structure quota for long-cycle clinical-trial deals in 2027?
Direct Answer Biotech B2B sales orgs structure quota for long-cycle clinical-trial deals by abandoning the annual SaaS number entirely. Instead they run a layered architecture: phase-gated credit that retires quota in tranches as a deal de-…
Read full answer ↗